cbdMD financials at a glance
Year | Year | 2019 | 2020 | 2021 | 2022 | 2018 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$23.65M | $41.88M | $44.48M | $35.40M | $0.46M | $24.16M | $0.00M |
GM % | Gross Margin % |
|
61.37% | 62.96% | 67.41% | 63.09% | 77.34% | 62.01% | 0.00% |
OM | Operating Margin |
|
-60.72% | -40.81% | -44.10% | -48.90% | 0.00% | -38.37% | 0.00% |
EPS | Earnings Per Share |
|
$-31.82 | $-16.89 | $-5.83 | $0.00 | |||
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
10.1m | 27.72m | 52.13m | 1.29m | 0m | 60.68m | 2.96m |
OCF | Operating Cash Flow |
|
$-15.38M | $-10.66M | $-14.09M | $-14.97M | $-5.57M | $-4.30M | $0.00M |
FCF | Free Cash Flow |
|
$-16.58M | $-11.98M | $-14.44M | $-15.66M | $-5.59M | $-4.60M | $0.00M |
FCFS | Free Cash Flow Per Share |
|
$-0.93 | $-0.28 | $-0.31 | $-0.33 | $-0.77 | $-4.09 | $0.00 |